Strittmatter Publication – QCB

Strittmatter Publication

October 25, 2017

Brady Strittmatter (Hollenhorst lab) was second author on a paper in the Journal of Biological Chemistry, Phosphorylation of the oncogenic transcription factor ERG in prostate cells dissociates polycomb repressive complex 2 allowing target gene activation, published in September 2017.

Trainee Spotlight

Morgan Nyman

My research focuses on developing and understanding cancer therapeutics that specifically target diseased tissue inhibiting one-carbon metabolism, and more specifically purine synthesis pathway, within the cell.

Fun Fact: I am a big fan of Jurassic Park.

Degree Program: Chemistry

Lab: Dann

Undergrad Institution: Gannon University

More Trainees

Stephen Ratvasky

My research focuses on the development of anticancer metallodrugs capable of spatiotemporally controlled therapeutic radical generation. Piggybacking triggerable ligand-based radical generation with metal-based antitumor reactivity has the potential to give metallodrugs with higher potency that can be administered at lower doses than those currently used in the clinic."

Fun Fact: I have three pet rats, two of which are named after a pair of Nobel prize-winning organic chemists famous for exploring cycloaddition reactions. Can you guess who?

Degree Program: Inorganic Chemistry

Lab: Zaleski

Undergraduate Institution: Duquesne University

More Trainees

© 2023 QCB. All Rights Reserved.